✦ LIBER ✦

Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis–associated liver disease

✍ Scribed by Peter Witters; Louis Libbrecht; Tania Roskams; Kris De Boeck; Lieven Dupont; Marijke Proesmans; François Vermeulen; Birgitta Strandvik; Anders Lindblad; Xavier Stéphenne; Etienne Sokal; Serge Gosseye; Sam Heye; Geert Maleux; Raymond Aerts; Diethard Monbaliu; Jacques Pirenne; Ilse Hoffman; Frederik Nevens; David Cassiman

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 632 KB
Volume: 53
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.24183

No coin nor oath required. For personal study only.

✦ Synopsis

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.